TSE:APS Aptose Biosciences (APS) Stock Price, News & Analysis → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free APS Stock Alerts C$2.00 0.00 (0.00%) (As of 03/18/2024 ET) Add Compare Share Share Today's RangeC$2.00▼C$2.1250-Day RangeC$1.85▼C$3.3552-Week RangeC$1.85▼C$13.65Volume5,869 shsAverage Volume6,367 shsMarket CapitalizationC$31.42 millionP/E RatioN/ADividend Yield0.39%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Get Aptose Biosciences alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About Aptose Biosciences Stock (TSE:APS)Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.Read More APS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APS Stock News HeadlinesJanuary 31, 2024 | finance.yahoo.comAptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment OptionDecember 20, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Wednesday (APS)March 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.December 9, 2023 | finance.yahoo.comAptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual MeetingNovember 30, 2023 | finance.yahoo.comAptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive RoleNovember 10, 2023 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comAptose Reports Results for the Third Quarter 2023November 2, 2023 | theglobeandmail.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingMarch 19, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… November 2, 2023 | finance.yahoo.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingOctober 30, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug TuspetinibOctober 26, 2023 | finance.yahoo.comAptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023October 20, 2023 | markets.businessinsider.comPromising Prospects of Tuspetinib Drive Buy Rating for Aptose Biosciences: An Analyst’s PerspectiveOctober 7, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Friday (APS)August 25, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Thursday (APS)August 22, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Monday (APS)August 11, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Reports Results for the Second Quarter 2023August 11, 2023 | finance.yahoo.comAptose Reports Results for the Second Quarter 2023August 7, 2023 | theglobeandmail.comAptose Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (APS)July 21, 2023 | theglobeandmail.comAptose Biosciences: Stocks Undervalued by Analyst Consensus on TSX (APS)June 27, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Biosciences Meets Nasdaq Minimum Bid Price ComplianceJune 5, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Biosciences Provides Update on Reverse Stock SplitMay 31, 2023 | finance.yahoo.comAptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023May 26, 2023 | seekingalpha.comAptose to sell up to $25M stock in the U.S.May 17, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Tuesday (APS)May 11, 2023 | finance.yahoo.comAptose Biosciences Inc.'s (TSE:APS) Path To ProfitabilityMay 10, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc down on Wednesday (APS)See More Headlines Receive APS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/18/2024Next Earnings (Estimated)3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:APS CUSIPN/A CIKN/A Webaptose.com Phone+1-647-4799828FaxN/AEmployees31Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($10.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-49,250,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-180.44% Return on Assets-81.22% Debt Debt-to-Equity Ratio14.27 Current Ratio1.59 Quick Ratio5.41 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$1.25 per share Price / Cash Flow1.60 Book ValueC$1.03 per share Price / Book1.94Miscellaneous Outstanding Shares15,710,000Free FloatN/AMarket CapC$31.42 million OptionableNot Optionable Beta1.44 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. William G. Rice Ph.D. (Age 59)Chairman, Pres & CEO Mr. Gregory K. Chow CPA (Age 45)MBA, BA, Sr. VP, CFO & Principal Accounting Officer Mr. Ernest Kitt B.S.M.S, VP of Devel. & Technical OperationsDr. Stephen B. Howell (Age 73)Chief Medical Officer Mr. Peter MurrayDirector of Clinical Devel.Key CompetitorsDevonian Health GroupCVE:GSDCovalon TechnologiesCVE:COVIBEX TechnologiesCVE:IBTAcasti PharmaCVE:ACSTAntibe TherapeuticsTSE:ATEView All Competitors APS Stock Analysis - Frequently Asked Questions How have APS shares performed in 2024? Aptose Biosciences' stock was trading at C$3.35 at the beginning of the year. Since then, APS shares have decreased by 40.3% and is now trading at C$2.00. View the best growth stocks for 2024 here. When is Aptose Biosciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our APS earnings forecast. What other stocks do shareholders of Aptose Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aptose Biosciences investors own include Aptose Biosciences (APTO), Aurinia Pharmaceuticals (AUPH), Advanced Micro Devices (AMD), NVIDIA (NVDA), Aurora Cannabis (ACB), Adobe (ADBE), AltaGas (ALA), Aphria (APHA), Algonquin Power & Utilities (AQN) and Badger Daylighting (BAD). How do I buy shares of Aptose Biosciences? Shares of APS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:APS) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportThe world’s greatest investmentPorter & CompanyMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.